Terug
Dagbereik
€ 8,69
€ 9,23
52-Weeksbereik
€ 3,87
€ 11,43
Volume
1.664.670
50D / 200D Gem.
€ 10,16
/
€ 6,87
Vorige Slotkoers
€ 8,84
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,8 | 0,3 |
| P/B | 1,0 | 2,9 |
| ROE % | -41,9 | 3,7 |
| Net Margin % | -122,1 | 3,8 |
| Rev Growth 5Y % | 17,6 | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 11,00
+20.7%
Low: € 10,00
High: € 12,00
Forward K/W
25,7
Forward WPA
€ 0,34
WPA Groei (sch.)
+0,0%
Omzet Sch.
850 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,46
€ 0,45 – € 0,46
|
870 M | 1 |
| FY2029 |
€ 0,47
€ 0,46 – € 0,47
|
890 M | 1 |
| FY2028 |
€ 0,43
€ 0,40 – € 0,45
|
870 M | 2 |
Belangrijkste Punten
Revenue grew 17,56% annually over 5 years — strong growth
Debt/Equity of 0,44 — conservative balance sheet
Negative free cash flow of -46,35M
Revenue growth is decelerating — 1Y growth trails 5Y average by 20,76%
ROIC of 0,24% — low return on invested capital
Interest coverage of 0,13× — tight debt servicing
Groei
Revenue Growth (5Y)
17,56%
Revenue (1Y)-3,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-41,88%
ROIC0,24%
Net Margin-122,06%
Op. Margin1,05%
Veiligheid
Debt / Equity
0,44
Current Ratio3,32
Interest Coverage0,13
Waardering
P/E Ratio
-1,81
P/B Ratio0,96
EV/EBITDA293,55
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3,20% | Revenue Growth (3Y) | 4,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17,56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 894,66M | Net Income (TTM) | -1,09B |
| ROE | -41,88% | ROA | -31,71% |
| Gross Margin | 47,10% | Operating Margin | 1,05% |
| Net Margin | -122,06% | Free Cash Flow (TTM) | -46,35M |
| ROIC | 0,24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 3,32 |
| Interest Coverage | 0,13 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -1,81 | P/B Ratio | 0,96 |
| P/S Ratio | 2,21 | PEG Ratio | 0,00 |
| EV/EBITDA | 293,55 | Dividend Yield | 0,00% |
| Market Cap | 1,98B | Enterprise Value | 2,77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 894,66M | 924,22M | 822,45M | 527,16M | 468,46M |
| Net Income | -1,09B | -9,42M | -22,87M | 48,31M | 60,88M |
| EPS (Diluted) | -5,03 | -0,04 | -0,12 | 0,45 | 0,57 |
| Gross Profit | 421,38M | 462,64M | 405,96M | 243,01M | 215,06M |
| Operating Income | 9,42M | 77,43M | 37,52M | 58,62M | 74,17M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,44B | 4,55B | 4,55B | 992,93M | 920,19M |
| Total Liabilities | 1,37B | 1,40B | 1,42B | 105,56M | 79,82M |
| Shareholders' Equity | 2,07B | 3,14B | 3,13B | 887,37M | 840,38M |
| Total Debt | 912,61M | 906,24M | 897,53M | 0,0 | 1,29M |
| Cash & Equivalents | 129,00M | 170,61M | 163,24M | 44,47M | 75,60M |
| Current Assets | 576,94M | 589,23M | 585,93M | 626,80M | 591,45M |
| Current Liabilities | 174,01M | 154,32M | 145,47M | 77,84M | 53,60M |